Spotlight op kinderen en adolescenten met diabetes
Array
Diabetes is een groeiend probleem in zowel volwassenen als kinderen, en als meer mensen worden getroffen door de aandoening, zodat de intensiteit van het onderzoek en de discussie rond het beheer opties toeneemt. De recente aandacht voor diabetes in de pediatrische populatie wordt gemarkeerd in een tijdige speciale aandacht nummer van Diabetes Management, een peer reviewed tijdschrift gepubliceerd door Future Medicine Ltd Type 1 diabetes is de meest voorkomende vorm van diabetes bij kinderen, echter, diabetes type 2 in kindergeneeskunde en adolescenten is nu ook op de stijging. Er zijn unieke uitdagingen die betrokken zijn bij het beheer van deze chronische aandoening bij kinderen en deze uitdagingen varieren patienten de transitie door de kindertijd naar adolescentie en vroege volwassenheid.
Spotlight on pediatric and adolescent diabetes
Diabetes is a growing problem in adults and children alike, and, as more people are affected by the condition, so the intensity of research and the debate surrounding management options increases. The recent focus on diabetes in the pediatric population is highlighted in a timely special focus issue of Diabetes Management, a peer reviewed journal published by Future Medicine Ltd. Type 1 diabetes is the most common form of diabetes in children, however, Type 2 diabetes in pediatrics and adolescents is now also on the rise. There are unique challenges involved in the management of this chronic condition in children and these challenges vary as patients transition through childhood into adolescence and early adulthood.
The content of the special issue has been driven by two esteemed Guest Editors, Chief Pediatrician and clinical researcher Denis Daneman of the University of Toronto, Canada, and a pediatric clinical scientist, David Dunger, from the University of Cambridge, UK. The support of both of the Guest Editors, one working on either side of the Atlantic Ocean, is of key importance when approaching this globally relevant topic.
“Diabetes remains a day-to-day challenge for people with the condition, whether Type 1 or Type 2. We hope that this Special Focus issue of Diabetes Management contributes in some tangible manner to lessening the burden of diabetes in childhood.†explains Daneman, Guest Editor of the issue and an Associate Editor of Diabetes Management.
A range of editorial, interview, perspective and review articles in this special focus issue highlight the specific care needs of diabetic children as they grow and reach different life stages. The articles also look at a number of different complications, such as retinopathy, microalbuminuria, and diabetic ketoacidosis, and how these should be handled in the pediatric population.
As science improves, so too should the accuracy of managing diabetes in young people. “It is our distinct hope that the pace of change in management of Type 1 diabetes in children and youth moves ahead in the years to come as the fruits of basic and applied science no longer require that we give the wrong amount of insulin in the wrong place at the wrong time, nor that we apply guesswork in closing the loop, nor that behavior plays such a pivotal role in treatment success.†comment Daneman and Dunger in the issue’s opening article.
A full listing of articles included in the issue is available at www.futuremedicine.com/toc/
The editorial office is now actively soliciting contributions of reviews, perspectives and editorial articles for Diabetes Management. For a full range of article types included in Diabetes Management please see our Author Guidelines. If you are interested in contributing any of the article types listed then please contact the Managing Commissioning Editor, Laura McGuinness l.mcguinness@futuremedicine.
Throughout the month of November we also have a “Buy Two for the price of Three†offer on all pay per view articles in the special focus issue.
The content of the special issue has been driven by two esteemed Guest Editors, Chief Pediatrician and clinical researcher Denis Daneman of the University of Toronto, Canada, and a pediatric clinical scientist, David Dunger, from the University of Cambridge, UK. The support of both of the Guest Editors, one working on either side of the Atlantic Ocean, is of key importance when approaching this globally relevant topic.
“Diabetes remains a day-to-day challenge for people with the condition, whether Type 1 or Type 2. We hope that this Special Focus issue of Diabetes Management contributes in some tangible manner to lessening the burden of diabetes in childhood.†explains Daneman, Guest Editor of the issue and an Associate Editor of Diabetes Management.
A range of editorial, interview, perspective and review articles in this special focus issue highlight the specific care needs of diabetic children as they grow and reach different life stages. The articles also look at a number of different complications, such as retinopathy, microalbuminuria, and diabetic ketoacidosis, and how these should be handled in the pediatric population.
As science improves, so too should the accuracy of managing diabetes in young people. “It is our distinct hope that the pace of change in management of Type 1 diabetes in children and youth moves ahead in the years to come as the fruits of basic and applied science no longer require that we give the wrong amount of insulin in the wrong place at the wrong time, nor that we apply guesswork in closing the loop, nor that behavior plays such a pivotal role in treatment success.†comment Daneman and Dunger in the issue’s opening article.
A full listing of articles included in the issue is available at www.futuremedicine.com/toc/
The editorial office is now actively soliciting contributions of reviews, perspectives and editorial articles for Diabetes Management. For a full range of article types included in Diabetes Management please see our Author Guidelines. If you are interested in contributing any of the article types listed then please contact the Managing Commissioning Editor, Laura McGuinness l.mcguinness@futuremedicine.
Throughout the month of November we also have a “Buy Two for the price of Three†offer on all pay per view articles in the special focus issue.
